Skip Navigation


European Journal of Heart Failure Advance Access originally published online on April 19, 2009
European Journal of Heart Failure 2009 11(5):525-528; doi:10.1093/eurjhf/hfp044
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
11/5/525    most recent
hfp044v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Lund, L. H.
Right arrow Articles by Mancini, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lund, L. H.
Right arrow Articles by Mancini, D. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2009. For permissions please email: journals.permissions@oxfordjournals.org.

Growth hormone resistance in severe heart failure resolves after cardiac transplantation

Lars H. Lund1,*, Pamela Freda2, Jill J. Williams3,4, John J. LaManca5, Thierry H. LeJemtel6 and Donna M. Mancini3

1 Department of Cardiology, Karolinska University Hospital, N305, 171 76 Stockholm, Sweden
2 Division of Endocrinology, College of Physicians and Surgeons, Columbia University, New York, NY, USA
3 Division of Cardiology, College of Physicians and Surgeons, Columbia University, New York, NY, USA
4 Institute of Human Nutrition, College of Physicians and Surgeons, Columbia University, New York, NY, USA
5 Salisbury University, Salisbury, MD, USA
6 Department of Medicine, Section of Cardiology, Tulane University School of Medicine, New Orleans, LA, USA

* Corresponding author. Tel: +46 8 51774975, Fax: +46 8 311044, Email: lars.lund{at}alumni.duke.edu


   Abstract

Aims: Severe heart failure (HF) is associated with cachexia; this is often reversed post cardiac transplantation (HTx) with frequent development of obesity. Growth hormone (GH) resistance is common in HF and may contribute to cachexia. Whether GH resistance resolves post HTx is unknown. We aimed to confirm that HF is associated with GH resistance and to test the hypothesis that GH resistance resolves post HTx.

Methods and results: We measured GH, insulin-like growth factor-1 (IGF-1), and body composition in 10 HF patients awaiting HTx, in 18 patients 11 ± 8 months post HTx, and seven controls. Body mass index was 23.5 ± 3.2 in HF patients and 29.3 ± 5.7 post HTx. HTx patients had gained 14 ± 8 kg since HTx. GH was elevated in HF (control: 0.21 ± 0.25; HF: 1.13 ± 1.19; HTx: 0.11 ± 0.13 ng/mL; P < 0.007), while IGF-1 was higher in HTx (control: 114 ± 57; HF: 94 ± 52; HTx: 190 ± 106 ng/mL; P < 0.02). HTx had higher total body and abdominal fat %.

Conclusion: GH resistance is present in severe HF and resolves post HTx. These findings should be confirmed through larger trials.

Key Words: Heart failure • Cachexia • Cardiac transplantation • Growth hormone • Insulin-like growth factor-1

Received November 21, 2008; Revised January 31, 2009; Accepted February 4, 2009


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Eur J Heart FailHome page
L. H. Lund, J. J. Williams, P. Freda, J. J. LaManca, T. H. LeJemtel, and D. M. Mancini
Ghrelin resistance occurs in severe heart failure and resolves after heart transplantation
Eur J Heart Fail, August 1, 2009; 11(8): 789 - 794.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.